Alzheimer's disease (AD) currently presents one of the biggest healthcare issues in the
developed countries. There is no effective treatment capable of slowing down disease …

Alzheimer's dis ease (AD) is a leading cause of mortality in the developed world with 70%
risk attributable to genetics. The remaining 30% of AD risk is hypothesized to include …

Neurodegenerative disorders are commonly erratic influenced by various factors including
lifestyle, environmental, and genetic factors. In recent observations, it has been …

Objectives Epidemiological evidence linking diet, one of the most important modifiable
lifestyle factors, and risk of Alzheimer's disease (AD) is rapidly increasing. However, there is …

A nutritional approach to prevent, slow, or halt the progression of disease is a promising
strategy that has been widely investigated. Much epidemiologic data suggests that …

The blood-brain barrier (BBB) is the highly specialized and selective crossing area between
blood and brain, essential for brain homeostasis and functioning, formed by the endothelial …

Many neurodegenerative and neuropsychiatric disorders have been reported to coincide
with the dysregulation of metal ions in the body and central nervous system. However, in …

Alzheimer's disease (AD) is a major global health problem today and is the most common
form of dementia. AD is characterized by the formation of β-amyloid (Aβ) plaques and …

Disruption of the intracellular balance between free radicals and the antioxidant system is a
prominent and early feature in the neuropathology of Alzheimer's disease (AD). Selenium, a …

A few studies have assessed the association between omega-3 polyunsaturated fatty acids
(n-3 PUFA) and cognitive impairment (CI) in very old adults. The aim of this study was to …